Multiple signaling pathways are often dysregulated in cancer. Pathways like PI3K/AKT/mTOR, MAPK/ERK, and Wnt/β-catenin are essential for cell survival, proliferation, and metabolism. Aberrations in these pathways can result from mutations, amplifications, or deletions of pathway components, leading to uncontrolled cell growth and survival.